Mangoceuticals annual revenue
2022
2023
2024
2025
Mangoceuticals Revenue Growth & History (MGRX)
Mangoceuticals reported $456,021 in revenue for fiscal 2025, a decrease of 25.96% from the previous fiscal year.
View full Mangoceuticals company overviewMangoceuticals annual revenue and growth
| Fiscal year | Period ended | Revenue | Change | Growth |
|---|---|---|---|---|
| 2025 | 2025-12-31 | $456,021 | −$159,852 | −25.96% |
| 2024 | 2024-12-31 | $615,873 | −$115,620 | −15.81% |
| 2023 | 2023-12-31 | $731,493 | $722,554 | +8083.16% |
| 2022 | 2022-12-31 | $8,939 | — | — |
Mangoceuticals quarterly revenue
Q1.23
Q2.23
Q3.23
Q4.23
Q1.24
Q2.24
Q3.24
Q4.24
Q1.25
Q2.25
Q3.25
Q4.25
Q1.26
Q2.26
| Fiscal quarter | Period ended | Revenue | Change | YoY growth |
|---|---|---|---|---|
| Q2 2026 | 2026-06-30 | $68,757 | −$99,352 | −59.10% |
| Q1 2026 | 2026-03-31 | $67,864 | −$41,442 | −37.91% |
| Q4 2025 | 2025-12-31 | $94,360 | −$10,887 | −10.34% |
| Q3 2025 | 2025-09-30 | $84,246 | −$49,122 | −36.83% |
| Q2 2025 | 2025-06-30 | $168,109 | $4,946 | +3.03% |
| Q1 2025 | 2025-03-31 | $109,306 | −$104,789 | −48.95% |
| Q4 2024 | 2024-12-31 | $105,247 | −$139,127 | −56.93% |
| Q3 2024 | 2024-09-30 | $133,368 | −$111,792 | −45.60% |
| Q2 2024 | 2024-06-30 | $163,163 | $21,926 | +15.52% |
| Q1 2024 | 2024-03-31 | $214,095 | $113,373 | +112.56% |
| Q4 2023 | 2023-12-31 | $244,374 | — | — |
| Q3 2023 | 2023-09-30 | $245,160 | — | — |
| Q2 2023 | 2023-06-30 | $141,237 | — | — |
| Q1 2023 | 2023-03-31 | $100,722 | — | — |
Mangoceuticals revenue growth trends
Mangoceuticals's latest reported quarter, Q2 2026, generated $68,757 in revenue, a decrease of 59.10% year over year.
About the data
What revenue means
Revenue is the top-line amount a company reports from selling goods and services before expenses are deducted. Fiscal periods can differ from calendar years, so each table includes the exact period end date.
Financial data
Standardized company financials
TickerStat standardizes company financial facts for consistent comparison. Derived growth rates use the displayed values and are not guidance or forecasts.
Review Mangoceuticals source filings ↗